BCPC · Balchem Corp
$178.51
+1.37 (+0.77%)
At close · Aug 14
Market Cap
$5.69B
Shares
31.88M
Balchem Corp Earnings Call Transcripts
Every quarterly earnings call for Balchem Corp (BCPC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲23.4%
$244.27M
$25.25M
'22 Q3
22-11-04
▲9.1%
$232.53M
$21.41M
'22 Q4
23-02-24
▲1.6%
$232.54M
$22.71M
'23 Q1
23-04-28
▼2.3%
$231.25M
$30.11M
'23 Q2
23-07-28
▼5.9%
$229.95M
$29.07M
'23 Q3
23-10-27
▼1.6%
$228.70M
$26.65M
'23 Q4
24-02-16
▲3.1%
$239.66M
$28.99M
'24 Q1
24-05-03
▲1.2%
$234.08M
$32.07M
'24 Q2
24-07-26
▲4.3%
$239.94M
$33.84M
'24 Q3
24-10-25
▲4.9%
$240.00M
$33.58M
'24 Q4
25-02-21
▲4.5%
$250.52M
$37.05M
'25 Q1
25-04-24
▲9.1%
$255.47M
$38.28M
'25 Q2
25-07-31
▲11.5%
$267.56M
$40.29M
'25 Q3
25-10-21
▲9.8%
$263.62M
$39.23M
'25 Q4
26-02-20
▲8.1%
$270.71M
$40.28M
'26 Q1
26-04-30
LATEST
▲11.2%
$284.00M
$44.62M
'26 Q2
26-07-31
Earnings call
FY26 · Q2
2026-07-31
Balchem Second Quarter 2026 Financial Results Conference Call
Confident tone
Animal Nutrition & Health (ANH) performance
Choline cognition / Alzheimer's study
Credit facility and interest rate
Revenue
$284.00M
▲ 11.2% YoY Diluted EPS
$1.39
▲ 18.8% YoY Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-30
Balchem Corp Q1 FY2026 Earnings Call
Confident tone
Specialty Products and Plant Nutrition
Vidacholine research and marketing
Input cost inflation and Middle East conflict
Revenue
$270.71M
▲ 8.1% YoY Diluted EPS
$1.25
▲ 10.6% YoY Gross margin
37.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-20
Balchem Corp Q4 FY2025 Earnings Call
Confident tone
International geographic expansion
Animal Nutrition & Health – dairy and monogastric
Human Nutrition & Health demand trends
Revenue
$263.62M
▲ 9.8% YoY Diluted EPS
$1.21
▲ 17.5% YoY Gross margin
35.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Balchem Corp Q3 FY2025 Earnings Call
Confident tone
Human Nutrition and Health demand
Record financial results and growth streak
Specialty Products expansion
Revenue
$267.56M
▲ 11.5% YoY Diluted EPS
$1.24
▲ 20.4% YoY Gross margin
35.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Balchem Corp Q2 FY2025 Earnings Call
Confident tone
Record financial results and growth across all segments
Human Nutrition & Health segment performance
Capital allocation and share repurchases
Revenue
$255.47M
▲ 9.1% YoY Diluted EPS
$1.17
▲ 19.4% YoY Gross margin
36.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Balchem Corp Q1 FY2025 Earnings Call
Confident tone
Record Q1 financial results
Tariffs and global trade environment
Human Nutrition & Health segment
Revenue
$250.52M
▲ 4.5% YoY Diluted EPS
$1.13
▲ 27% YoY Gross margin
35.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Balchem Corp Q4 FY2024 Earnings Call
Confident tone
Margin Outlook and Mix
Animal Nutrition & Health Segment
Quarterly and Full-Year Financial Results
Revenue
$240.00M
▲ 4.9% YoY Diluted EPS
$1.03
▲ 25.6% YoY Gross margin
36.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-25
Balchem Corp Q3 FY2024 Earnings Call
Confident tone
Human Nutrition & Health segment strength
Animal Nutrition & Health softness
Margin expansion and outlook
Revenue
$239.94M
▲ 4.3% YoY Diluted EPS
$1.03
▲ 14.4% YoY Gross margin
35.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-26
Balchem Corp Q2 FY2024 Earnings Call
Confident tone
Human Nutrition & Health segment performance
Optifolin+ new product launch
Specialty Products and performance gases
Revenue
$234.08M
▲ 1.2% YoY Diluted EPS
$0.98
▲ 5.4% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Balchem Corp Q1 FY2024 Earnings Call
Positive tone
VitaCholine Marketing / NY Jets Partnership
Human Nutrition & Health (HNH) Segment Performance
Animal Nutrition & Health Headwinds
Revenue
$239.66M
▲ 3.1% YoY Diluted EPS
$0.89
▲ 27.1% YoY Gross margin
34.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-16
Balchem Corp Q4 FY2023 Earnings Call
Confident tone
Animal Nutrition & Health Segment
Financial Results
CureMark / Microencapsulation
Revenue
$228.70M
▼ 1.6% YoY Diluted EPS
$0.82
▲ 24.2% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-27
Balchem Corp Q3 FY2023 Earnings Call
Revenue
$229.95M
▼ 5.9% YoY Diluted EPS
$0.90
▲ 15.4% YoY Gross margin
33.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-28
Balchem Corp Q2 FY2023 Earnings Call
Revenue
$231.25M
▼ 2.3% YoY Diluted EPS
$0.93
▲ 1.1% YoY Gross margin
33.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-28
Balchem Corp Q1 FY2023 Earnings Call
Revenue
$232.54M
▲ 1.6% YoY Diluted EPS
$0.70
▼ 21.3% YoY Gross margin
31.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-24
Balchem Corp Q4 FY2022 Earnings Call
Revenue
$232.53M
▲ 9.1% YoY Diluted EPS
$0.66
▼ 13.2% YoY Gross margin
29.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-04
Balchem Corp Q3 FY2022 Earnings Call
Revenue
$244.27M
▲ 23.4% YoY Diluted EPS
$0.78
▲ 1.3% YoY Gross margin
28.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-29
Balchem Corp Q2 FY2022 Earnings Call
Revenue
$236.69M
▲ 17% YoY Diluted EPS
$0.92
▲ 31.4% YoY Gross margin
30.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-29
Balchem Corp Q1 FY2022 Earnings Call
Revenue
$228.87M
▲ 23.3% YoY Diluted EPS
$0.89
▲ 23.6% YoY Gross margin
31.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Balchem Corp Q4 FY2021 Earnings Call
Revenue
$213.13M
▲ 17.9% YoY Diluted EPS
$0.76
▲ 11.8% YoY Gross margin
30.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-29
Balchem Corp Q3 FY2021 Earnings Call
Revenue
$197.87M
▲ 13% YoY Diluted EPS
$0.77
▲ 16.7% YoY Gross margin
30.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-30
Balchem Corp Q2 FY2021 Earnings Call
Revenue
$202.37M
▲ 16.7% YoY Diluted EPS
$0.70
▲ 7.7% YoY Gross margin
29.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Balchem Corp Q1 FY2021 Earnings Call
Revenue
$185.66M
▲ 6.4% YoY Diluted EPS
$0.72
▲ 18% YoY Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-19
Balchem Corp Q4 FY2020 Earnings Call
Revenue
$180.71M
▲ 8.5% YoY Diluted EPS
$0.68
▲ 7.9% YoY Gross margin
31.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Balchem Corp Q3 FY2020 Earnings Call
Revenue
$175.14M
▲ 10.4% YoY Diluted EPS
$0.66
▲ 3.1% YoY Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Balchem Corp Q2 FY2020 Earnings Call
Revenue
$173.35M
▲ 7.3% YoY Diluted EPS
$0.65
▲ 6.6% YoY Gross margin
31.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-01
Balchem Corp Q1 FY2020 Earnings Call
Revenue
$174.44M
▲ 11.1% YoY Diluted EPS
$0.61
▲ 5.2% YoY Gross margin
31.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-21
Balchem Corp Q4 FY2019 Earnings Call
Revenue
$166.53M
▲ 1.8% YoY Diluted EPS
$0.63
▲ 0% YoY Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
9326
CUSIP
057665200
13F (30d)
387 filings
382 filers
Visit website
Investor relations